Scarica l'app Stockscreener
1.71
3.01%
0.05
Dopo l'orario di chiusura:
1.71
Precedente Chiudi:
$1.66
Aprire:
$1.78
Volume 24 ore:
1,757
Relative Volume:
0.05
Capitalizzazione di mercato:
$10.32M
Reddito:
-
Utile/perdita netta:
$-33.65M
Rapporto P/E:
-0.3843
EPS:
-4.45
Flusso di cassa netto:
$-20.83M
1 W Prestazione:
+15.93%
1M Prestazione:
-5.00%
6M Prestazione:
-31.05%
1 anno Prestazione:
-32.94%
Intervallo 1D:
$1.6587
$1.79
Intervallo di 1 settimana:
$1.52
$1.81
Portata 52W:
$1.15
$3.69
Minerva Neurosciences Inc Stock (NERV) Company Profile
Nome
Minerva Neurosciences Inc
Settore
Industria
Telefono
617-600-7373
Indirizzo
1601 TRAPELO ROAD, WALTHAM, MA
Confronta NERV con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
NERV
Minerva Neurosciences Inc
|
1.71 | 10.32M | 0 | -33.65M | -20.83M | -4.45 |
|
VRTX
Vertex Pharmaceuticals Inc
|
490.47 | 128.67B | 11.02B | -535.60M | -978.00M | -2.20 |
|
REGN
Regeneron Pharmaceuticals Inc
|
585.49 | 60.99B | 14.20B | 4.41B | 3.54B | 38.28 |
|
ARGX
Argen X Se Adr
|
599.87 | 36.96B | 2.19B | 833.04M | -1.28B | 12.71 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
236.75 | 29.89B | 2.25B | -278.16M | -42.59M | -2.17 |
|
ONC
Beigene Ltd Adr
|
252.77 | 25.74B | 3.81B | -644.79M | -669.77M | -6.24 |
Minerva Neurosciences Inc Stock (NERV) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2020-06-08 | Reiterato | H.C. Wainwright | Buy |
| 2020-05-14 | Iniziato | BTIG Research | Buy |
| 2019-10-02 | Reiterato | Chardan Capital Markets | Buy |
| 2019-09-25 | Iniziato | Chardan Capital Markets | Buy |
| 2019-09-18 | Iniziato | William Blair | Outperform |
| 2019-05-31 | Iniziato | H.C. Wainwright | Buy |
| 2017-09-01 | Iniziato | Citigroup | Buy |
| 2017-03-06 | Ripresa | Jefferies | Buy |
| 2016-05-12 | Ripresa | Jefferies | Buy |
Mostra tutto
Minerva Neurosciences Inc Borsa (NERV) Ultime notizie
Minerva Neurosciences (NASDAQ:NERV) Share Price Crosses Below 200 Day Moving Average – What’s Next? - Defense World
Minerva Neurosciences (NASDAQ:NERV) Earns Sell Rating from Analysts at StockNews.com - Defense World
12 Health Care Stocks Moving In Monday's After-Market Session - Benzinga
Minerva Neurosciences (NASDAQ:NERV) Coverage Initiated by Analysts at StockNews.com - Defense World
CLASS ACTION UPDATE for TILE, NERV and QSR: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of Shareholders - ACCESS Newswire
CLASS ACTION UPDATE for BABA, NAK and NERV: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of Shareholders - ACCESS Newswire
Parkinson's Disease Pipeline Analysis and Clinical Trials - openPR.com
Minerva Neurosciences stock hits 52-week low at $1.29 - Investing.com Australia
Minerva Neurosciences stock hits 52-week low at $1.29 By Investing.com - Investing.com South Africa
Major depressive disorder Drugs Market 2034: Clinical Trials, - openPR.com
Minerva Neurosciences regains Nasdaq compliance By Investing.com - Investing.com Australia
FINAL DEADLINE ALERT: ROSEN, LEADING AND RESPECTED INVESTOR COUNSEL, Encourages Minerva Neurosciences, Inc. Investors with Large Losses to Secure Counsel Before Important February 8 Deadline – NERV - Business Wire
Minerva Neurosciences regains Nasdaq compliance - Investing.com
StockNews.com Begins Coverage on Minerva Neurosciences (NASDAQ:NERV) - Defense World
Parkinson's Disease Clinical Pipeline | 130+ Companies Advancing the Future of Treatment - openPR
Intra-Cellular deal, Axsome settlement drive neurological index recovery - BioWorld MedTech
Minerva Neurosciences Reports Improved 2024 Financials - TipRanks
Minerva Neurosciences (NASDAQ:NERV) Coverage Initiated at StockNews.com - Defense World
Minerva Neurosciences’ (NERV) Neutral Rating Reiterated at HC Wainwright - Defense World
Minerva Neurosciences stock hits 52-week low at $1.7 By Investing.com - Investing.com Australia
Investor Network: Minerva Neurosciences Inc to Host Earnings Call - ACCESS Newswire
Minerva Neurosciences stock hits 52-week low at $1.7 - Investing.com
Minerva Neurosciences Inc to Host Earnings Call - ACCESS Newswire
Minerva Neurosciences: Q4 Earnings Snapshot - CTPost
Hold Rating for Minerva Neurosciences Amidst Uncertainty Over Roluperidone and Financial Constraints - TipRanks
Minerva Neurosciences Inc reports results for the quarter ended December 31Earnings Summary - TradingView
Minerva Neurosciences: Q4 Earnings Snapshot -February 25, 2025 at 07:33 am EST - Marketscreener.com
Minerva Neurosciences Reports Fourth Quarter and Fiscal Year 2024 Financial Results and Business Updates - The Manila Times
From $30M Loss to Profit: How Minerva Turned Finances Around While Navigating FDA Hurdles - StockTitan
Minerva Neurosciences, Inc. SEC 10-K Report - TradingView
Minerva Neurosciences (NERV) Expected to Announce Quarterly Earnings on Thursday - Defense World
Minerva Neurosciences stock hits 52-week low at $1.86 - Investing.com India
Minerva Neurosciences Inc expected to post a loss of $1.05 a shareEarnings Preview - TradingView
Minerva Neurosciences Stock Hits 52-Week Low at $2.03 - MSN
Minerva Neurosciences stock hits 52-week low at $2.02 By Investing.com - Investing.com Nigeria
Minerva Neurosciences stock hits 52-week low at $2.02 - Investing.com
Minerva Neurosciences Inc Azioni (NERV) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
1.00%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):